With over 0.15 million Viemed Healthcare Inc. (VMD) shares trading Monday and a closing price of $8.10 on the day, the dollar volume was approximately $1.24 million. The shares have shown a positive half year performance of 3.32% and its price on 01/23/23 gained nearly 2.79%. Currently, there are 38.23M common shares owned by the public and among those 35.00M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 4 analysts who have offered their price forecasts for VMD have a consensus price objective of $12.10. The analysts have set the share’s price value over the next 12 months at a high of $15.00 and a low of $10.85. The average price target is 37.69% above its recent price level and an upside to the estimated low will see the stock gain 25.35% over that period. But an upside of 46.0% will see the stock hit the forecast high price target while median target price for the stock is $11.28.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
Insiders at the company have transacted a total of 55 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 33 of these insider trades were purchases, accounting for 269,953 shares. Insider sales of the common stock occurred on 22 occasions, with total insider shares sold totaling 101,864 shares.
The top 3 mutual fund holders in Viemed Healthcare Inc. are Thrivent Small Cap Stock Fund, Thrivent Variable Product – Small, and Vanguard Total Stock Market Index. Thrivent Small Cap Stock Fund owns 2.28 million shares of the company’s stock, all valued at over $17.27 million. The company bought an additional 0.3 million shares recently to bring their total holdings to about 6.01% of the shares outstanding. Thrivent Variable Product – Small bought 5838.0 shares to see its total holdings expand to 1.11 million shares valued at over $8.42 million and representing 2.93% of the shares outstanding. Vanguard Total Stock Market Index now owns shares totaling to 2.39% of the shares outstanding.
Shares of Viemed Healthcare Inc. (NASDAQ: VMD) opened at $8.02, up $0.14 from a prior closing price of $7.88. However, the script later moved the day high at 8.10, up 2.79%. The company’s stock has a 5-day price change of 2.92% and 40.87% over the past three months. VMD shares are trading 7.14% year to date (YTD), with the 12-month market performance up to 73.45% higher. It has a 12-month low price of $3.56 and touched a high of $8.25 over the same period. VMD has an average intraday trading volume of 55.68K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.25%, 10.16%, and 28.26% respectively.
Institutional ownership of Viemed Healthcare Inc. (NASDAQ: VMD) shares accounts for 48.64% of the company’s 38.23M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $435.21M and a beta (3y monthly) value of 0.88. The stock’s trailing 12-month PE ratio is 30.80, while the earnings-per-share (ttm) stands at $0.26. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.50% over the week and 3.54% over the month.
Analysts forecast that Viemed Healthcare Inc. (VMD) will achieve an EPS of $0.04 for the current quarter, $0.05 for the next quarter and $0.32 for 2023. The lowest estimate earnings-per-share for the quarter is $0.04 while analysts give the company a high EPS estimate of $0.05. Earnings per share for the fiscal year are expected to decrease by -71.20%, and 100.00% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 4 brokerage firm advisors rate Viemed Healthcare Inc. (VMD) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 4 Wall Street analysts polled rate the stock as a buy, while 0 of the 4 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the VMD, a number of firms have released research notes about the stock. RBC Capital Mkts stated their Outperform rating for the stock in a research note on March 05, 2021, with the firm’s price target at $13.
